Top Markets
Coin of the day
Aptose Biosciences Inc. Aptose Biosciences Inc.

Aptose Biosciences Inc.

APS
Hisse Senetlerindeki Sıralama #35076
Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to... Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to discovering and advancing personalized therapeutic solutions for challenging oncology cases, primarily within the United States. Its robust pipeline features several key clinical programs: APTO-253, currently in Phase 1a/b trials, targets patients with relapsed or refractory blood cancers like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another candidate, HM43239, is undergoing Phase 1/2 evaluation for the treatment of relapsed or refractory AML. Aptose is also developing luxeptinib, which is in Phase 1a/b clinical studies for individuals battling relapsed or refractory B-cell malignancies, encompassing chronic lymphocytic leukemia, small lymphocytic lymphoma, various non-Hodgkin's lymphomas, as well as AML and HR MDS. Furthermore, the company is progressing with APL-581, a program centered on a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor. Aptose maintains strategic alliances with CrystalGenomics, Inc. and OHM Oncology. Incorporated in 1986 and headquartered in Toronto, Canada, the company was formerly known as Lorus Therapeutics Inc., changing its name to Aptose Biosciences Inc. in August 2014.
Hisse Fiyatı
$1.76
Son senkronizasyon: 2026-07-03
Piyasa Değeri
$4.50M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
41.53%
Ülke
CA
Ticaret Aptose Biosciences Inc. (APS)

Kategori

Aptose Biosciences Inc. (APS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.76 - 2026-07-01

Gün sonu en düşük fiyat: $4.49K - 1996-04-01
Aptose Biosciences Inc. için hisse fiyatı geçmişi: 1996 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -4.34%
2025 677.87%
2024 -91.63%
2023 -72.76%
2022 -64.07%
2021 -64.29%
2020 12.71%
2019 99.28%
2018 11.56%
2017 62.99%
2016 -55.72%
2015 -58.73%
2014 -1.07%
2013 57.23%
2012 69.88%
2011 -81.30%
2010 -47.11%
2009 58.35%
2008 -77.14%
2007 -10.06%
2006 -14.70%
2005 -57.23%
2004 -28.50%
2003 124.84%
2002 -54.03%
2001 -22.17%
2000 55.42%
1999 161.59%
1998 -65.73%
1997 -16.29%
1996 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE